Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. Securities Purchase Agreement On December 9, 2025, TuHURA Biosciences, Inc. (the “Company”) entered into a securit
Other Events. On December 9, 2025, the Company issued a press release announcing the pricing of the Offering, a copy of which is filed herewith as Exhibit 99.1
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Series A Purchase Warrant 4.2 Form of Series B Purchase Warrant 4.3 Form